These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 25900655)

  • 1. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.
    Miquel S; Leclerc M; Martin R; Chain F; Lenoir M; Raguideau S; Hudault S; Bridonneau C; Northen T; Bowen B; Bermúdez-Humarán LG; Sokol H; Thomas M; Langella P
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
    Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P
    Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.
    Martín R; Chain F; Miquel S; Lu J; Gratadoux JJ; Sokol H; Verdu EF; Bercik P; Bermúdez-Humarán LG; Langella P
    Inflamm Bowel Dis; 2014 Mar; 20(3):417-30. PubMed ID: 24418903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis.
    Qiu X; Zhang M; Yang X; Hong N; Yu C
    J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
    Sokol H; Pigneur B; Watterlot L; Lakhdari O; Bermúdez-Humarán LG; Gratadoux JJ; Blugeon S; Bridonneau C; Furet JP; Corthier G; Grangette C; Vasquez N; Pochart P; Trugnan G; Thomas G; Blottière HM; Doré J; Marteau P; Seksik P; Langella P
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16731-6. PubMed ID: 18936492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecalibacterium prausnitzii Strain HTF-F and Its Extracellular Polymeric Matrix Attenuate Clinical Parameters in DSS-Induced Colitis.
    Rossi O; Khan MT; Schwarzer M; Hudcovic T; Srutkova D; Duncan SH; Stolte EH; Kozakova H; Flint HJ; Samsom JN; Harmsen HJ; Wells JM
    PLoS One; 2015; 10(4):e0123013. PubMed ID: 25910186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis.
    Zhou Y; Xu H; Xu J; Guo X; Zhao H; Chen Y; Zhou Y; Nie Y
    AMB Express; 2021 Feb; 11(1):33. PubMed ID: 33641084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate mediates anti-inflammatory effects of
    Lenoir M; Martín R; Torres-Maravilla E; Chadi S; González-Dávila P; Sokol H; Langella P; Chain F; Bermúdez-Humarán LG
    Gut Microbes; 2020 Nov; 12(1):1-16. PubMed ID: 33054518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecalibacterium prausnitzii produces butyrate to decrease c-Myc-related metabolism and Th17 differentiation by inhibiting histone deacetylase 3.
    Zhang M; Zhou L; Wang Y; Dorfman RG; Tang D; Xu L; Pan Y; Zhou Q; Li Y; Yin Y; Zhao S; Wu J; Yu C
    Int Immunol; 2019 Jul; 31(8):499-514. PubMed ID: 30809639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
    Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
    Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.
    Rossi O; van Berkel LA; Chain F; Tanweer Khan M; Taverne N; Sokol H; Duncan SH; Flint HJ; Harmsen HJ; Langella P; Samsom JN; Wells JM
    Sci Rep; 2016 Jan; 6():18507. PubMed ID: 26725514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
    Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
    J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CCR6 and CXCR6 by Gut-Derived CD4
    Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F
    Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of live, but not inactivated, Faecalibacterium prausnitzii has a preventive effect on dextran sodium sulfate‑induced colitis in mice.
    Kawade Y; Sakai M; Okamori M; Morita M; Mizushima K; Ueda T; Takagi T; Naito Y; Itoh Y; Shimada T
    Mol Med Rep; 2019 Jul; 20(1):25-32. PubMed ID: 31115531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation.
    Huang XL; Zhang X; Fei XY; Chen ZG; Hao YP; Zhang S; Zhang MM; Yu YQ; Yu CG
    World J Gastroenterol; 2016 Jun; 22(22):5201-10. PubMed ID: 27298563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecalibacterium prausnitzii inhibits interleukin-17 to ameliorate colorectal colitis in rats.
    Zhang M; Qiu X; Zhang H; Yang X; Hong N; Yang Y; Chen H; Yu C
    PLoS One; 2014; 9(10):e109146. PubMed ID: 25275569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.
    Martín R; Miquel S; Chain F; Natividad JM; Jury J; Lu J; Sokol H; Theodorou V; Bercik P; Verdu EF; Langella P; Bermúdez-Humarán LG
    BMC Microbiol; 2015 Mar; 15():67. PubMed ID: 25888448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Culture with
    Kim H; Jeong Y; Kang S; You HJ; Ji GE
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32466189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.